Facebook
Twitterhttps://digital.nhs.uk/services/data-access-request-service-darshttps://digital.nhs.uk/services/data-access-request-service-dars
The National Cancer Registration and Analysis Service (NCRAS) at Public Health England supplies cancer registration data to NHS Digital. This data is available to be linked to other data held by NHS Digital in order to provide notifications on an individual's cancer status, be available to support research studies and to identify potential research participants for clinical trials.
NCRAS is the population-based cancer registry for England. It collects, quality assures and analyses data on all people living in England who are diagnosed with malignant and pre-malignant neoplasms, with national coverage since 1971.
The Cancer Registration dataset comprises England data to the present day, and Welsh data up to April 2017.
Timescales for dissemination of agreed data can be found under 'Our Service Levels' at the following link: https://digital.nhs.uk/services/data-access-request-service-dars/data-access-request-service-dars-process Standard response
Facebook
TwitterAge-standardised proportion of adults (16+) who met the recommended guidelines of consuming five or more portions of fruit and vegetables a day by gender. To help reduce the risk of deaths from chronic diseases such as heart disease, stroke, and cancer. The Five-a-day programme was introduced to increase fruit and vegetable consumption within the general population. Its central message is that people should eat at least five portions of fruit and vegetables a day; that a variety of fruit and vegetables should be consumed and that fresh, frozen, canned and dried fruit, vegetables and pulses all count in making up these portions. The programme includes educational initiatives to increase awareness of the Five-a-day message and the benefits of fruit and vegetable consumption, along with more direct schemes to increase access to fruit and vegetables, such as the school fruit scheme and community initiatives. Monitoring of fruit and vegetable consumption is key to evaluating the success of the policy, both at the level of individual schemes and at a more general level. The England average, at the 95% confidence level (LCL = lower confidence interval; UCL = upper confidence interval). Related to: National Indicator Library - NHS England Digital (editor note: was https://indicators.ic.nhs.uk/webview/)
Facebook
Twitterhttps://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.
Facebook
TwitterThis table shows working age population that has a disability and Employment, unemployment, economic activity and inactivity rates by disability (includes Equalities Act Core disabled, DDA & work-limiting disabled) The definition of ‘disability’ under the Equality Act 2010 shows a person has a disability if: they have a physical or mental impairment the impairment has a substantial and long-term adverse effect on their ability to perform normal day-to-day activities For the purposes of the Act, these words have the following meanings: 'substantial' means more than minor or trivial 'long-term' means that the effect of the impairment has lasted or is likely to last for at least twelve months (there are special rules covering recurring or fluctuating conditions) 'normal day-to-day activities' include everyday things like eating, washing, walking and going shopping There are additional provisions relating to people with progressive conditions. People with HIV, cancer or multiple sclerosis are protected by the Act from the point of diagnosis. People with some visual impairments are automatically deemed to be disabled. 18/03/2015 Data has been reweighted in line with the latest ONS estimates. 2013 data is not available for disability measures from this survey. Due to changes in the health questions on the Annual Population Survey there is quite a large discontinuity in the estimates from the Apr 2012 to Mar 2013 period onwards. These became available again from the Apr 2013 to March 2014 period as new variables. 95% confidence interval of percent figure (+/-).
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Disability in activities of daily living (ADL) is a common unmet need among people with advanced respiratory disease. Rehabilitation could help prolong independence, but indicators for timely intervention in this population are lacking. This study aimed to identify trajectories of disability in ADLs over time, and predicting factors, in advanced respiratory disease. Multi-site prospective cohort study in people with advanced non-small cell lung cancer (NSCLC), chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD), recruited from hospital or community services, throughout England. Disability in basic (Barthel Index) and instrumental (Lawton–Brody IADL Scale) ADLs were assessed monthly over six months. Visual graphical analysis determined individual trajectories. Multivariate logistic regression examined predictors of increasing disability in basic and instrumental ADLs. Between March 2020 and January 2021, we recruited participants with a diagnosis of NSCLC (n = 110), COPD (n = 72), and ILD (n = 19). 151 participants completed ≥3 timepoints and were included in the longitudinal analysis. Mobility limitation was an independent predictor of increasing disability in instrumental ADLs (odds ratio, 1⋅41 [CI: 1⋅14–1⋅74], p = 0⋅002). Mobility limitation could be used as a simple referral criterion across people with advanced respiratory disease to ensure timely rehabilitation that targets independence in ADLs. To our knowledge this is the first prospective cohort study of trajectories of disability in activities of daily living (ADL) in advanced respiratory disease, including recruitment during the Covid-19 pandemic.It adds to existing evidence by identifying individual variability in trajectories of ADL disability which are undetected at group level.The identification of mobility limitation as a predictor of increasing ADL disability, while controlling for malignant or non-malignant respiratory disease, is novel and has practical utility.Our findings have implications for clinical care, as early identification of functional decline through use of mobility limitation tools could flag early referral to rehabilitation services, potentially preventing or delaying forthcoming functional decline and avoiding reactive crisis management.Mobility limitation is a predictor of increasing disability in activities of daily living in advanced disease, which could be used to flag early referral to rehabilitation services, to help prevent or delay forthcoming functional decline and avoid reactive crisis management To our knowledge this is the first prospective cohort study of trajectories of disability in activities of daily living (ADL) in advanced respiratory disease, including recruitment during the Covid-19 pandemic. It adds to existing evidence by identifying individual variability in trajectories of ADL disability which are undetected at group level. The identification of mobility limitation as a predictor of increasing ADL disability, while controlling for malignant or non-malignant respiratory disease, is novel and has practical utility. Our findings have implications for clinical care, as early identification of functional decline through use of mobility limitation tools could flag early referral to rehabilitation services, potentially preventing or delaying forthcoming functional decline and avoiding reactive crisis management. Mobility limitation is a predictor of increasing disability in activities of daily living in advanced disease, which could be used to flag early referral to rehabilitation services, to help prevent or delay forthcoming functional decline and avoid reactive crisis management
Facebook
TwitterDisability and mobility data for London and Rest of the UK, for working age (16-64) and all adults (16+). Data includes population with mobility difficulties, people who use special equipment to help be mobile, people with a mobility impairment, and people who currently have 'DDA' Disability. The definition of ‘DDA disability’ under the Equality Act 2010 shows a person has a disability if: they have a physical or mental impairment the impairment has a substantial and long-term adverse effect on their ability to perform normal day-to-day activities For the purposes of the Act, these words have the following meanings: 'substantial' means more than minor or trivial 'long-term' means that the effect of the impairment has lasted or is likely to last for at least twelve months (there are special rules covering recurring or fluctuating conditions) 'normal day-to-day activities' include everyday things like eating, washing, walking and going shopping There are additional provisions relating to people with progressive conditions. People with HIV, cancer or multiple sclerosis are protected by the Act from the point of diagnosis. People with some visual impairments are automatically deemed to be disabled. Find out more about the Life Opportunities Survey (LOS).
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Facebook
Twitterhttps://digital.nhs.uk/services/data-access-request-service-darshttps://digital.nhs.uk/services/data-access-request-service-dars
The National Cancer Registration and Analysis Service (NCRAS) at Public Health England supplies cancer registration data to NHS Digital. This data is available to be linked to other data held by NHS Digital in order to provide notifications on an individual's cancer status, be available to support research studies and to identify potential research participants for clinical trials.
NCRAS is the population-based cancer registry for England. It collects, quality assures and analyses data on all people living in England who are diagnosed with malignant and pre-malignant neoplasms, with national coverage since 1971.
The Cancer Registration dataset comprises England data to the present day, and Welsh data up to April 2017.
Timescales for dissemination of agreed data can be found under 'Our Service Levels' at the following link: https://digital.nhs.uk/services/data-access-request-service-dars/data-access-request-service-dars-process Standard response